Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in IMVT — Immunovant, Inc.

CIK 1068837 ATLANTA, GA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,390,369
+$2,041,905 QoQ
Shares Held
87,993
+62.1% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 226 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 19% None 81%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. IMVT ranks #55 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 505,219 $250,957,432
2 PTGX
Protagonist Therapeutics, Inc
 571,618 $70,068,932
3 TWST
Twist Bioscience Corp
 671,866 $69,121,573
4 SRRK
Scholar Rock Holding Corp
 890,607 $48,983,385
5 KRYS
Krystal Biotech, Inc.
 124,442 $46,251,357
6 TGTX
Tg Therapeutics, Inc.
 819,253 $45,009,759
7 PTCT
Ptc Therapeutics, Inc.
 539,319 $43,992,249
8 PRAX
Praxis Precision Medicines, Inc.
 122,227 $40,920,376

All Filings in IMVT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,390,369 87,993
2026-03-31 $1,348,464 54,286
2025-12-31 $1,363,299 53,631
2025-09-30 $203,934 12,651
2025-06-30 $297,456 18,591
2025-03-31 $582,238 34,069
2024-12-31 $888,276 35,861
2024-09-30 $1,060,172 37,186
2024-06-30 $1,717,214 65,046
2024-03-31 $2,614,201 80,910
2023-12-31 $3,570,812 84,757
2023-09-30 $4,128,958 107,553
2023-06-30 $405,559 21,379
2023-03-31 $260,800 16,815
2022-12-31 $298,466 16,815
2022-09-30 $86,026 15,417
2022-06-30 $60,126 15,417
2022-03-31 $84,947 15,417
2021-12-31 $131,352 15,417
2021-09-30 $132,800 15,282
2021-06-30 $161,530 15,282
2021-03-31 $276,128 17,215
2020-12-31 $731,557 15,838
2020-09-30 $411,652 11,698